Implanted heart device manufacturer Medtronic of Minneapolis is asking doctors to discontinue use of a component in its newest defibrillator models.
Medtronic said the component, an electrical wire that connects the defibrillator to a patient's heart, is prone to defect and has been linked to hundreds of malfunctions and may have been involved in five fatalities, The New York Times reported Monday.
The company also urged the approximately 235,000 patients who have been outfitted with the devices to have them immediately examined by doctors to ensure they are properly reading heart rhythm data.
The move was welcomed by Daniel Schultz, director of the Center for Devices and Radiological Health at the U.S. Food and Drug Administration.
"Medtronic's decision to voluntarily remove its Sprint Fidelis defibrillation leads from the market is in the best interest of patient safety," Schultz said in a statement.
"These electronic wires are prone to fracture in a small number of patients which can cause the defibrillator to deliver unnecessary shocks or not operate at all. Based on our initial review of reported adverse events, some deaths and major complications have occurred after the leads have fractured," he said.
Copyright 2007 by United Press International
Related stories:
Defibrillators save lives, don't diminish quality of life
Implantable cardioverter-defibrillators (ICDs) reduce the risk of death from sudden cardiac arrest (SCA) among patients with heart failure, and they do so without significantly altering a person's quality of life, say researchers from Duke University Medical Center.
Risk factors for sudden death for adult muscular dystrophy identified
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease. The results of the multicenter study, led by the Indiana University School of Medicine, are reported in the June 19 issue of the
New England Journal of Medicine.
Cardiac devices and advanced heart failure: Are we selecting the wrong patients?
Patients with advanced heart failure may be receiving implantable cardiac devices that do not help them because they are too ill to benefit from the treatment, a Saint Louis University study found.
Heart defibrillator company signs decree
The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.
In-home AEDs don't improve sudden cardiac arrest survival
David Callans, MD, a professor of cardiovascular medicine at the University of Pennsylvania School of Medicine, will be available to comment on the New England Journal of Medicine study on the use of automated external defibrillators (AEDs) for sudden cardiac arrests that occur in the home. Callans, author of the journal editorial that accompanies the new study, serves as associate director of electrophysiology for the Penn Health System, and has extensive experience in studying ventricular arrhythmias.
Angina drug potentially useful against heart rhythm disorders
A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.
Researchers Hack Defibrillators
Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks. A team of researchers from three leading universities has demonstrated that patients’ private medical information could be extracted and their devices reprogrammed without the patients’ authorization or knowledge.
Herbal remedy useful for heart failure, review finds
Adding another twist to the ongoing debate over the value of an herbal treatment for patients with heart failure, a new review of existing research suggests that hawthorn extract “significantly” improves symptoms.